Cargando…
COVID-19 Induced Myxedema Madness
Background: Corona Virus Disease 2019 (COVID-19) pandemic was first reported in December 31st, 2019 in Wuhan, China. The clinical presentation is variable, including a variety of neuropsychiatric related symptoms. Myxedema Madness is a rare and severe neuropsychiatric complication of hypothyroidism...
Autores principales: | Tal, Noa, Veriker, Robbie, Averbukh, Yelena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089490/ http://dx.doi.org/10.1210/jendso/bvab048.1890 |
Ejemplares similares
-
ODP491 Levothyroxine Withdrawal Presenting as Myxedema Madness
por: Trusty, Rhonda-Kaye, et al.
Publicado: (2022) -
SAT503 Acute Psychosis and Paranoia as an Initial Manifestation of Myxedema Madness
por: Atam, Sarin, et al.
Publicado: (2023) -
SAT-480 Myxedema Madness: A Rare Case of Severe Hypothyroidism Presenting as Psychosis
por: Kohm, Kevin, et al.
Publicado: (2020) -
SAT-624 Amiodarone-Induced Myxedema Coma
por: Rana, Sanah, et al.
Publicado: (2019) -
SUN-550 Pressor Refractory, Liothyronine Responsive Myxedema Cardiogenic Shock without Myxedema Coma
por: Willis, Cornelia, et al.
Publicado: (2019)